LezDo TechMed announced the introduction of a next-generation medical chronology product designed to present an organized ...
The U.S. pharmaceutical industry in 2025 remains one of the nation’s most dynamic and profitable economic sectors.
This retrospective study is a key component of Telo's expanding, multi-center MRD validation program and is designed to evaluate the clinical utility of Telo's blood-based TeloView®MRD. The University ...
Corteva , a global leader in agricultural technology, and Hexagon Bio, a biotechnology company pioneering a new way to discover nature-derived medicine, today announced a multi-million-dollar joint ...
Respiratory inhaler devices are essential tools for delivering medication directly into the lungs for the treatment and management of respiratory conditions such as asthma, chronic obstructive ...
Biomarker Therapy in 2025: More Lung Cancer Options, Competition in New Drug Classes, ctDNA Advances
This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...
Researchers at University of Tsukuba have decoded the nuclear genome of Amorphochlora amoebiformis, a unicellular marine alga ...
The gene therapies for cardiomyopathies market is poised for strong growth as advancements in genomic medicine accelerate the ...
News-Medical.Net on MSN
RNAConnect launches the Ultramarathonrt Direct RNA‑Seq Kit to advance nanopore-based native RNA sequencing
RNAConnect, a life science company providing next generation tools to the RNA community, today announced the commercial availability of the UltraMarathonRT® Direct RNA‑Seq (uMRT DRS) Kit, a native‑RNA ...
Neoantigen vaccines are at the forefront of cancer research, driving personalized immunotherapy and improving outcomes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results